- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02293174
Retinal Fundus Camera Evaluation
June 6, 2022 updated by: Topcon Medical Systems, Inc.
TRC-NW400 Retinal Fundus Camera Image Evaluation and Instrument Comparison Protocol
Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Establish a normal baseline setting configuration for image capture using the Topcon TRC-NW400 non-mydriatic retinal camera.
While also comparing the images to other manufacturer's retinal cameras
Study Type
Observational
Enrollment (Actual)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Oakland, New Jersey, United States, 07436
- Topcon Medical Systems, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Normal subjects will be recruited from Topcon Medical Systems.
Description
Inclusion Criteria:
- Subjects with no known ocular diseases
Exclusion Criteria:
- Subjects with known ocular diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Healthy Eyes
Willing and able subjects with normal and healthy eyes
|
Retinal Fundus Camera
Retinal Fundus Camera
Retinal Fundus Camera
Retinal Fundus Camera
Retinal Fundus Camera
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fundus Image Grading
Time Frame: 1 Hour
|
Determining the best display to reflect the real color of the retina
|
1 Hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Danny Leung, Clinical Trial Manager
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
November 11, 2014
First Submitted That Met QC Criteria
November 13, 2014
First Posted (Estimate)
November 18, 2014
Study Record Updates
Last Update Posted (Actual)
June 8, 2022
Last Update Submitted That Met QC Criteria
June 6, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- TOPCON-003-2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.